Abiopharma

Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting

MAIA Biotechnology Presents Trial in Progress Poster for Pivotal Phase 3 Clinical Trial of Novel Telomere Targeting Agent at 2026 Annual Meeting of American Society of Clinical Oncology

PSQ Holdings Announces Updates to Board of Directors

IMFINZI® (durvalumab) plus IMJUDO® (tremelimumab-actl) combined with lenvatinib and TACE reduced the risk of disease progression or death by 30% in embolization-eligible unresectable liver cancer in EMERALD-3 Phase III trial

Robbins Geller Rudman & Dowd LLP and Motley Rice LLC Announce Proposed Settlement in the Shoals Technologies Securities Litigation

U.S. Marine Corps Expands Autonomous Fires Capability with Oshkosh Defense ROGUE-Fires Block 2 Award

Iveda Launches Real-Time Zero-Shot AI Detection, Enabling Users to Instantly Build Custom AI Models With a Single Prompt

Vertex to Present at the 46th Annual William Blair Growth Stock Conference

ASML reports transactions under its current share buyback program